CD177 and prostate carcinoma: We applied this methodology to screen the large (>1010 members) naive human phage display library n-CoDeR26 for antibodies to cell surface receptors differentially expressed between two cell types: DU145 prostate cancer (target) cells and Jurkat (nontarget) T cells.